Loading news article.

Newsbenzinga

Stifel Initiates Coverage On Immunome with Hold Rating, Announces Price Target of $24

Oct 1, 2026, 06:53 ET · Published

Article summary

Please check the source for details.

An excerpt from the original article.

Loading comments…